PLURICARE
Board
2 directors, last change in 2024Director
appointed by deed of 06-10-2021
term without a fixed end
listed in the 2026 annual accounts, filed on 28-10-2026
Director
appointed by deed of 31-01-2024
term without a fixed end
listed in the 2026 annual accounts, filed on 28-10-2026
- Signing authorityThe articles say who may bind the company, for example by signing a contract.
- Each director alonedeed of 31-01-2024
Mandates through the years
3 names, the dashed line is todayBoardEarliermandate already running before its first mention
Mandates as a list
- NURNBERG Etta
- Director, appointed by deed of 06-10-2021, still in office
- LIPSKI Alexandre
- Director, since before 06-10-2021
- LIPSKI Samuel Michaël
- Manager, from before 31-03-2022 to 31-01-2024
Control
Shareholders
LIPSKI Alexandre, NURNBERG Etta, LIPSKI Samuel
This company
PLURICARE
Equity €1.1m
Profit €20,092 in 2026
Capital
- Contribution
- €6,500
- Source
- 2026 annual accounts
Articles of association
deed of 31-01-2024 (in French)- DurationMost companies exist for an unlimited period, until they are dissolved.
- Unlimited
- Transfer restrictionThis rule says whether shareholders may sell their shares freely or need approval first.
- “Tous les frais de procédure et d'expertise étant pour moitié à charge du cédant et pour moitié à charge du ou des acquéreurs…”
- Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
- Last Monday of September at 18:00
Founders
Stated in the deed
deed of 31-01-2024 ↗
- LIPSKI Alexandre
- NURNBERG Etta
- LIPSKI Samuel
Capital transactions
Capital over time
- 31-01-2024 Converted to unavailable equity · €8,360
- 31-01-2024 Converted to uncalled contributions · €12,100